- Home
- Free App Analytics
- Janssen ICONIC
- Janssen ICONIC Vs. Biofourmis Clinical Trials™
Janssen ICONIC vs Biofourmis Clinical Trials™ Usage & Stats
Janssen eCOA App is intended for use to collect patient reported outcomes relating to a clinical trial. Patients must be given accounts by a participating site in order to log in to the app.
- Apple App Store
- Free
- Medical
Store Rank
- -
Biofourmis Clinical Trials™ empowers clinical trial participants with a user-friendly mobile app tailored to enhance your engagement and contribution to clinical research. Leveraging advanced technology, our platform provides personalized solutions tailored to meet the unique needs of your trial participation, seamlessly integrating into your daily life. Easily connect with your trial team and access study-related information.
Contribute to data collection via connected devices, and access digital tools including informed consent, remote data capture, and virtual visits to actively engage in your trial journey. Our app offers educational resources and complete support for managing devices, promoting a seamless and supportive trial experience.
Disclaimer: To access the Biofourmis Clinical Trials™ app, you must seek advice and study screening from a participating clinician.
The app is for data collection purposes only, and does not make any diagnosis or clinical recommendations. You should directly seek advice from a health care provider before making any medical decisions.
Questions about Biofourmis Clinical Trials? Email support@biofourmis.com
- Apple App Store
- Free
- Medical
Store Rank
- -
Janssen ICONIC vs. Biofourmis Clinical Trials™ ranking comparison
Compare Janssen ICONIC ranking trend in the past 28 days vs. Biofourmis Clinical Trials™
Rank
No Data Available
Janssen ICONIC vs. Biofourmis Clinical Trials™ ranking by country comparison
Compare Janssen ICONIC ranking trend in the past 28 days vs. Biofourmis Clinical Trials™
No Data to Display
Compare to any site with our free trial
Janssen ICONIC VS.
Biofourmis Clinical Trials™
January 9, 2025